tiprankstipranks
Advertisement
Advertisement

Zylox-Tonbridge Sets Final 2025 Dividend and Confirms Payout Timetable

Story Highlights
  • Zylox-Tonbridge declared a final 2025 dividend of RMB 0.22 per share, reinforcing its shareholder return strategy.
  • The company updated the dividend timetable, setting May approval, June record and payment dates for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Zylox-Tonbridge Sets Final 2025 Dividend and Confirms Payout Timetable

Claim 55% Off TipRanks

Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has shared an announcement.

Zylox-Tonbridge Medical Technology Co., Ltd., a Hong Kong-listed medical technology company, has confirmed a final ordinary cash dividend of RMB 0.22 per share for the financial year ended 31 December 2025. The payment reflects the company’s ongoing practice of returning cash to shareholders and underscores its financial capacity to distribute profits while maintaining its position in the medical device sector.

The company updated investors that shareholder approval for the final dividend is scheduled for 13 May 2026, with key timetable dates now set, including an ex-dividend date of 27 May, a record date of 2 June and a payment date of 18 June 2026. Hong Kong dollar equivalents and applicable withholding tax details will be announced later, and Tricor Investor Services will manage the share registration process, giving shareholders clearer visibility on the distribution timeline and entitlement arrangements.

The most recent analyst rating on (HK:2190) stock is a Buy with a HK$28.00 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.

More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H

Zylox-Tonbridge Medical Technology Co., Ltd. is a Hong Kong-listed medical technology company focused on developing and supplying healthcare devices and related products. Its shares trade under stock code 02190, and the company serves investors through the Hong Kong market with an established board comprising executive, non-executive and independent non-executive directors.

The firm operates within the broader medical technology and healthcare equipment industry, relying on cash-generative operations that support regular dividend distributions. Its investor base includes shareholders accessing the stock via the Hong Kong share register, administered by Tricor Investor Services Limited in Central, Hong Kong, which handles entitlement and registration matters for corporate actions.

Average Trading Volume: 770,015

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$8.33B

Learn more about 2190 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1